Protease inhibitors in hepatitis C: from chronic disease to cure.
作者信息
Iqbal M, McCormick P A
出版信息
Ir Med J. 2011 Sep;104(8):230-1.
PMID:22125874
Abstract
摘要
相似文献
1
Protease inhibitors in hepatitis C: from chronic disease to cure.
Ir Med J. 2011 Sep;104(8):230-1.
2
[A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
MMW Fortschr Med. 2011 Jul 21;153(29-31):17.
3
Infectious diseases. First specific drugs raise hopes for hepatitis C.
Science. 2011 Apr 8;332(6026):159-60. doi: 10.1126/science.332.6026.159.
4
[Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
Pharm Unserer Zeit. 2011 Jan;40(1):60-7. doi: 10.1002/pauz.201100401.
5
[New times for the treatment of chronic hepatitis C].
Ugeskr Laeger. 2012 Mar 19;174(12):795.
6
Antiviral agents and hepatitis C.
N Y State Dent J. 2012 Jun-Jul;78(4):42-5.
7
Direct-acting antiviral (DAA) actions in treatment-naïve patients.
Clin Res Hepatol Gastroenterol. 2011 Dec;35 Suppl 2:S52-8. doi: 10.1016/S2210-7401(11)70008-0.
8
[Therapy of hepatitis C: new inhibitors as hammers against HCV].
MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:10-1.
9
Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
Rev Esp Quimioter. 2013 Sep;26(3):189-92.
10
Two drugs approved for chronic hepatitis C infection.
Am J Health Syst Pharm. 2011 Jul 1;68(13):1176. doi: 10.2146/news110042.
Zotero 插件